Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.

Giovanni GrignaniVanna Chiarion SileniCarmine PintoRoberta DepenniNicola FazioLuca GalliDario GiuffridaCarlo CarnaghiDomenico CilibertoDomenico C CorsiPaola QueiroloElena BenincasaFilippo VenturiniGennaro FazziNuno CostaPaolo Antonio Ascierto

Published in: Journal of translational medicine (2021)

Results from Italian patients enrolled in the avelumab EAP are consistent with the findings of the JAVELIN Merkel 200 trial and confirm the efficacy and safety of avelumab treatment in this population.

Keyphrases

end stage renal disease
clinical trial
newly diagnosed
ejection fraction
chronic kidney disease
randomized controlled trial
study protocol
peritoneal dialysis
quality improvement
phase ii
phase iii
open label
replacement therapy